Differentiated models of service delivery for antiretroviral treatment of HIV in sub-Saharan Africa: a rapid review protocol

被引:14
|
作者
Long, Lawrence [1 ,2 ]
Kuchukhidze, Salome [1 ]
Pascoe, Sophie [2 ]
Nichols, Brooke [1 ,2 ]
Cele, Refiloe [2 ]
Govathson, Caroline [2 ]
Huber, Amy [2 ]
Flynn, David [3 ]
Rosen, Sydney [1 ,2 ]
机构
[1] Boston Univ, Dept Global Hlth, Boston, MA 02215 USA
[2] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa
[3] Boston Univ, Alumni Med Lib, Boston, MA 02215 USA
基金
比尔及梅琳达.盖茨基金会;
关键词
Sub-Saharan Africa; HIV; differentiated care; Coverage; Effectiveness; Cost; Treatment; CARE; HEALTH;
D O I
10.1186/s13643-019-1210-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background To meet global targets for the treatment of HIV, high-prevalence countries are launching or expanding differentiated models of service delivery (DSD) for antiretroviral therapy (ART). Ongoing studies report on metrics specific to individual models of care, but little is known about the overall scale, impact, costs, and benefits of widespread implementation of DSD. We will conduct a rapid review of recent literature on DSD currently in use in sub-Saharan Africa and identify gaps in the literature with respect to the description of delivery models, coverage, effectiveness, and cost. Methods We will use an adapted version of the preferred reporting items for systematic reviews and meta-analysis protocols (PRISMA-P) for reporting. To avoid repeating earlier reviews, only sources reporting data on interventions conducted and/or patients starting antiretroviral treatment since 1 January 2016 will be included. Other inclusion criteria: must report on HIV-positive patients receiving antiretroviral therapy (ART) for the treatment of HIV/AIDS in sub-Saharan Africa; must describe an antiretroviral care intervention and identify the location, visit frequency, provider, patient group, and intervention intensity; and must report at least one of the following outcomes: population coverage, intervention uptake, treatment outcomes, cost or resource allocation, acceptability, or feasibility. Exclusion criteria: receiving ART as part of prevention of mother-to-child transmission (PMTCT) program or receiving preventive ART (PEP or PrEP). This review will include peer-reviewed articles and conference abstracts. Publication databases to be searched include PubMed, EMBASE, and Web of Science. For analysis, where possible, we will group the DSD by key characteristics (e.g., population served, visit frequency, visit location) and then report means and/or medians of coverage and outcomes with confidence intervals or IQRs. We will also descriptively compare and contrast different models of care, implementation challenges, and other non-quantitative information. Discussion This review will provide an initial picture of the status quo for the implementation of DSD in sub-Saharan Africa and identify directions for research and implementation support in the future. This big-picture analysis will be useful for ministries of health, implementers, and donor agencies to inform decision-making on DSD scale-up. Systematic review registration PROSPERO: CRD42019118230
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studies
    Davies, Mary-Ann
    Egger, Matthias
    Keiser, Olivia
    Boulle, Andrew
    AJAR-AFRICAN JOURNAL OF AIDS RESEARCH, 2009, 8 (03): : 329 - 338
  • [22] Rehabilitation approaches for children living with HIV in sub-Saharan Africa: a protocol for scoping review
    Stacy Maddocks
    Saul Cobbing
    Jill Hanass-Hancock
    Verusia Chetty
    Systematic Reviews, 8
  • [23] Rehabilitation approaches for children living with HIV in sub-Saharan Africa: a protocol for scoping review
    Maddocks, Stacy
    Cobbing, Saul
    Hanass-Hancock, Jill
    Chetty, Verusia
    SYSTEMATIC REVIEWS, 2019, 8 (01)
  • [24] HIV treatment as prevention: applicable in sub-Saharan Africa?
    Newell, Marie-Louise
    Iwuji, Collins
    LANCET INFECTIOUS DISEASES, 2016, 16 (07): : 754 - 755
  • [25] Improving access to treatment for HIV in sub-Saharan Africa
    Bautista-Arredondo, Sergio
    Wirtz, Veronika J.
    Bertozzi, Stefano M.
    BRITISH MEDICAL JOURNAL, 2010, 341
  • [26] A Scoping Review Protocol of Social Determinants of HIV/TB Coinfections in Sub-Saharan Africa
    Banda, Lucas
    Oladimeji, Olanrewaju
    METHODS AND PROTOCOLS, 2024, 7 (01)
  • [27] Maternal deaths and HIV treatment in sub-Saharan Africa
    Myer, Landon
    LANCET, 2013, 381 (9879): : 1699 - 1700
  • [28] Role of religious beliefs on antiretroviral treatment adherence among Pentecostal Christians in sub-Saharan Africa: a scoping review protocol
    Azia, Ivo
    Mukumbang, Ferdinand C.
    Shernaaz, Carelse
    Nyembezi, Anam
    BMJ OPEN, 2022, 12 (04):
  • [29] Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes
    Haas, Andreas D.
    Zaniewski, Elizabeth
    Anderegg, Nanina
    Ford, Nathan
    Fox, Matthew P.
    Vinikoor, Michael
    Dabis, Francois
    Nash, Denis
    Sinayobye, Jean d'Amour
    Niyongabo, Theodore
    Tanon, Aristophane
    Poda, Armel
    Adedimeji, Adebola A.
    Edmonds, Andrew
    Davies, Mary-Ann
    Egger, Matthias
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [30] Prevention of antiretroviral anarchy in sub-Saharan Africa
    Laing, R
    LANCET, 2001, 358 (9295): : 1819 - 1820